R60 — Triple Agonist
Triple GIP / GLP-1 / Glucagon Receptor Agonist · 60mg Research Vial
Meet the next generation of metabolic research. R60 delivers 60mg of a triple-action peptide engaging GIP, GLP-1, and glucagon receptors simultaneously, making it one of the most closely watched compounds in current metabolic research.
| Compound | Triple Agonist |
| Dose Per Vial | 60mg |
| Mechanism | Triple GIP, GLP-1 & glucagon receptor agonist |
| Category | Metabolic Research |
Why Researchers Choose R60
Triple Receptor ActivityEngages three distinct metabolic pathways — GIP, GLP-1, and glucagon — within a single molecule.
High-Interest CompoundThis triple agonist sits at the forefront of published metabolic research, giving researchers early access to next-gen peptide science.
Cold-Chain HandledStored and dispatched under controlled conditions from our facility to your door.
Format OptionsChoose vial, cartridge, or pen format below to suit your lab setup.
About the Triple Agonist
This compound is a synthetic peptide combining agonist activity at GIP, GLP-1, and glucagon receptors — a triple mechanism that has generated substantial interest across the metabolic research community for its broader receptor engagement compared to single- or dual-agonist compounds.
For laboratory research use only. Not for human or veterinary use, and not for human consumption. Supplied exclusively to verified BioCompounds UK account holders for in-vitro and analytical research purposes.
Been using this RTA60 for a while now and I have to say this is the best I’ve ever used from any supplier. Defo recommend bio compounds for this and any other peptide they sell
Perfect. So easy to order and super fast delivery
As usual my order arrived quickly
Always spot on!!!!! Customer service brilliant no questions ive ever had have gone unanswered cant reccomend these guys enough!!!!